ABCB5-Targeted Chemoresistance Reversal Inhibits Merkel Cell Carcinoma Growth.

MLA

Kleffel, Sonja, et al. “ABCB5-Targeted Chemoresistance Reversal Inhibits Merkel Cell Carcinoma Growth.” The Journal of Investigative Dermatology, vol. 136, no. 4, Apr. 2016, pp. 838–46. EBSCOhost, https://doi.org/10.1016/j.jid.2015.12.038.

APA

Kleffel, S., Lee, N., Lezcano, C., Wilson, B. J., Sobolewski, K., Saab, K. R., Mueller, H., Zhan, Q., Posch, C., Elco, C. P., DoRosario, A., Garcia, S. S., Thakuria, M., Wang, Y. E., Wang, L. C., Murphy, G. F., Frank, M. H., & Schatton, T. (2016). ABCB5-Targeted Chemoresistance Reversal Inhibits Merkel Cell Carcinoma Growth. The Journal of Investigative Dermatology, 136(4), 838–846. https://doi.org/10.1016/j.jid.2015.12.038

Chicago

Kleffel, Sonja, Nayoung Lee, Cecilia Lezcano, Brian J Wilson, Kristine Sobolewski, Karim R Saab, Hansgeorg Mueller, et al. 2016. “ABCB5-Targeted Chemoresistance Reversal Inhibits Merkel Cell Carcinoma Growth.” The Journal of Investigative Dermatology 136 (4): 838–46. doi:10.1016/j.jid.2015.12.038.